Report Detail

Request for Sample of this report

Service & Software Global Microarray-based Non-Invasive Prenatal Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4769187
    • |
  • 06 November, 2026
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Microarray-based Non-Invasive Prenatal Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.
This report is a detailed and comprehensive analysis for global Microarray-based Non-Invasive Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Microarray-based Non-Invasive Prenatal Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Microarray-based Non-Invasive Prenatal Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microarray-based Non-Invasive Prenatal Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microarray-based Non-Invasive Prenatal Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Microarray-based Non-Invasive Prenatal Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trisomy Detection
Microdeletion Syndromes
Other
Market segment by Application
Hospitals & Clinics
Independent Laboratories
Market segment by players, this report covers
Agilent Technologies
Ariosa Diagnostics (Roche)
BGI Group
Eurofins LifeCodexx GmbH
Illumina
Laboratory Corporation of America
Myriad Genetics
Natera
PerkinElmer Inc
Quest Diagnostics
Sequenom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microarray-based Non-Invasive Prenatal Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microarray-based Non-Invasive Prenatal Testing, with revenue, gross margin, and global market share of Microarray-based Non-Invasive Prenatal Testing from 2021 to 2026.
Chapter 3, the Microarray-based Non-Invasive Prenatal Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Microarray-based Non-Invasive Prenatal Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microarray-based Non-Invasive Prenatal Testing.
Chapter 13, to describe Microarray-based Non-Invasive Prenatal Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Microarray-based Non-Invasive Prenatal Testing by Type
    • 1.3.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Trisomy Detection
    • 1.3.4 Microdeletion Syndromes
    • 1.3.5 Other
  • 1.4 Global Microarray-based Non-Invasive Prenatal Testing Market by Application
    • 1.4.1 Overview: Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals & Clinics
    • 1.4.3 Independent Laboratories
  • 1.5 Global Microarray-based Non-Invasive Prenatal Testing Market Size & Forecast
  • 1.6 Global Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast by Region
    • 1.6.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region, (2021-2032)
    • 1.6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Agilent Technologies
    • 2.1.1 Agilent Technologies Details
    • 2.1.2 Agilent Technologies Major Business
    • 2.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Agilent Technologies Recent Developments and Future Plans
  • 2.2 Ariosa Diagnostics (Roche)
    • 2.2.1 Ariosa Diagnostics (Roche) Details
    • 2.2.2 Ariosa Diagnostics (Roche) Major Business
    • 2.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Ariosa Diagnostics (Roche) Recent Developments and Future Plans
  • 2.3 BGI Group
    • 2.3.1 BGI Group Details
    • 2.3.2 BGI Group Major Business
    • 2.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BGI Group Recent Developments and Future Plans
  • 2.4 Eurofins LifeCodexx GmbH
    • 2.4.1 Eurofins LifeCodexx GmbH Details
    • 2.4.2 Eurofins LifeCodexx GmbH Major Business
    • 2.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eurofins LifeCodexx GmbH Recent Developments and Future Plans
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Illumina Recent Developments and Future Plans
  • 2.6 Laboratory Corporation of America
    • 2.6.1 Laboratory Corporation of America Details
    • 2.6.2 Laboratory Corporation of America Major Business
    • 2.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Laboratory Corporation of America Recent Developments and Future Plans
  • 2.7 Myriad Genetics
    • 2.7.1 Myriad Genetics Details
    • 2.7.2 Myriad Genetics Major Business
    • 2.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Myriad Genetics Recent Developments and Future Plans
  • 2.8 Natera
    • 2.8.1 Natera Details
    • 2.8.2 Natera Major Business
    • 2.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Natera Recent Developments and Future Plans
  • 2.9 PerkinElmer Inc
    • 2.9.1 PerkinElmer Inc Details
    • 2.9.2 PerkinElmer Inc Major Business
    • 2.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 PerkinElmer Inc Recent Developments and Future Plans
  • 2.10 Quest Diagnostics
    • 2.10.1 Quest Diagnostics Details
    • 2.10.2 Quest Diagnostics Major Business
    • 2.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.11 Sequenom
    • 2.11.1 Sequenom Details
    • 2.11.2 Sequenom Major Business
    • 2.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Product and Solutions
    • 2.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sequenom Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Microarray-based Non-Invasive Prenatal Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Microarray-based Non-Invasive Prenatal Testing by Company Revenue
    • 3.2.2 Top 3 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
    • 3.2.3 Top 6 Microarray-based Non-Invasive Prenatal Testing Players Market Share in 2025
  • 3.3 Microarray-based Non-Invasive Prenatal Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Microarray-based Non-Invasive Prenatal Testing Market: Region Footprint
    • 3.3.2 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Type Footprint
    • 3.3.3 Microarray-based Non-Invasive Prenatal Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Microarray-based Non-Invasive Prenatal Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2032)
  • 6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
    • 6.3.1 North America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country
    • 7.3.1 Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region
    • 8.3.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
    • 9.3.1 South America Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country
    • 10.3.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Microarray-based Non-Invasive Prenatal Testing Market Drivers
  • 11.2 Microarray-based Non-Invasive Prenatal Testing Market Restraints
  • 11.3 Microarray-based Non-Invasive Prenatal Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Microarray-based Non-Invasive Prenatal Testing Industry Chain
  • 12.2 Microarray-based Non-Invasive Prenatal Testing Upstream Analysis
  • 12.3 Microarray-based Non-Invasive Prenatal Testing Midstream Analysis
  • 12.4 Microarray-based Non-Invasive Prenatal Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Microarray-based Non-Invasive Prenatal Testing. Industry analysis & Market Report on Microarray-based Non-Invasive Prenatal Testing is a syndicated market report, published as Global Microarray-based Non-Invasive Prenatal Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Microarray-based Non-Invasive Prenatal Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo